Search research articles
Contact Us
Filters
Showing results (211-220 of 218) with videos related to
Page
of 22
Sort By:
You have reached the last page of results.
This site can display upto 218 results.
The British Journal of Dermatology
|
September 14, 2011
Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo
T Dirschka, P Radny, R Dominicus, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 22, 2020
EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris - Part 1: treatment and monitoring recommendations
A Nast, C Smith, P I Spuls, et al.
The British Journal of Dermatology
|
September 10, 2017
The genetic basis for most patients with pustular skin disease remains elusive
R Mössner, D Wilsmann-Theis, V Oji, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
February 6, 2021
EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris - Part 2: specific clinical and comorbid situations
A Nast, C Smith, P I Spuls, et al.
The British Journal of Dermatology
|
December 21, 2012
Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis
T Dirschka, P Radny, R Dominicus, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 29, 2009
European S3-guidelines on the systemic treatment of psoriasis vulgaris
D Pathirana, A D Ormerod, P Saiag, et al.
Rheumatology (Oxford, England)
|
June 3, 2008
The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement
N Hunzelmann, E Genth, T Krieg, et al.
The Journal of Rheumatology
|
June 17, 2010
Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database
Jerome Avouac, Ulrich Walker, Alan Tyndall, et al.
Page
of 22
Search research articles
Search
Showing results (211-220 of 218) with videos related to
Sort By:
Page
of 22
You have reached the last page of results.
This site can display upto 218 results.
The British Journal of Dermatology
|
September 14, 2011
Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo
T Dirschka, P Radny, R Dominicus, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 22, 2020
EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris - Part 1: treatment and monitoring recommendations
A Nast, C Smith, P I Spuls, et al.
The British Journal of Dermatology
|
September 10, 2017
The genetic basis for most patients with pustular skin disease remains elusive
R Mössner, D Wilsmann-Theis, V Oji, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
February 6, 2021
EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris - Part 2: specific clinical and comorbid situations
A Nast, C Smith, P I Spuls, et al.
The British Journal of Dermatology
|
December 21, 2012
Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis
T Dirschka, P Radny, R Dominicus, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 29, 2009
European S3-guidelines on the systemic treatment of psoriasis vulgaris
D Pathirana, A D Ormerod, P Saiag, et al.
Rheumatology (Oxford, England)
|
June 3, 2008
The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement
N Hunzelmann, E Genth, T Krieg, et al.
The Journal of Rheumatology
|
June 17, 2010
Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database
Jerome Avouac, Ulrich Walker, Alan Tyndall, et al.
Page
of 22